Marshall Wace, LLP Mannkind Corp Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

A detailed history of Marshall Wace, LLP transactions in Mannkind Corp stock. As of the latest transaction made, Marshall Wace, LLP holds 711,810 shares of MNKD stock, worth $4.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

711,810

Previous 599,359 18.76%

Holding current value

$4.9 Million

Previous $3.13 Million 42.9%

% of portfolio

0.01%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$5.01 - $6.7 $563,379 - $753,421	112,451 Added 18.76%	711,810 $4.47 Million
Q2 2024 Aug 14, 2024	SELL	$4.05 - $5.43 $833,344 - $1.12 Million	-205,764 Reduced 25.56%	599,359 $3.13 Million
Q1 2024 May 15, 2024	SELL	$3.25 - $5.27 $3.68 Million - $5.97 Million	-1,133,705 Reduced 58.47%	805,123 $3.65 Million
Q4 2023 Feb 14, 2024	SELL	$3.34 - $4.29 $4.29 Million - $5.51 Million	-1,284,233 Reduced 39.85%	1,938,828 $7.06 Million
Q3 2023 Nov 14, 2023	BUY	$3.91 - $5.45 $7.93 Million - $11.1 Million	2,028,570 Added 169.83%	3,223,061 $13.3 Million
Q2 2023 Aug 14, 2023	BUY	$3.72 - $4.79 $4.24 Million - $5.46 Million	1,139,245 Added 2062.13%	1,194,491 $4.86 Million
Q1 2023 May 15, 2023	BUY	$3.95 - $5.63 $218,221 - $311,034	55,246 New	55,246 $226,000
Q2 2022 Aug 15, 2022	SELL	$2.67 - $4.77 $2.03 Million - $3.63 Million	-761,643 Reduced 95.58%	35,200 $134,000
Q1 2022 May 16, 2022	BUY	$2.62 - $4.45 $2.09 Million - $3.55 Million	796,843 New	796,843 $2.93 Million
Q4 2021 Feb 14, 2022	SELL	$4.05 - $5.37 $922,934 - $1.22 Million	-227,885 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$3.89 - $5.48 $886,472 - $1.25 Million	227,885 New	227,885 $991,000
Q1 2021 May 17, 2021	SELL	$3.14 - $6.14 $764,103 - $1.49 Million	-243,345 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$1.79 - $4.04 $435,587 - $983,113	243,345 New	243,345 $762,000

Others Institutions Holding MNKD

# of Institutions

244

Shares Held

148M

Call Options Held

1.62M

Put Options Held

802K

View Full List

About MANNKIND CORP

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.77B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

More about MNKD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Mannkind Corp Transaction History